The PE Ratio as of December 2025 (TTM) for Bicara Therapeutics Inc. Common Stock (BCAX) is 3.49

According to Bicara Therapeutics Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is 3.49. This represents a change of -134.41% compared to the average of -10.14 of the last 4 quarters.

Bicara Therapeutics Inc. Common Stock (BCAX) Historical PE Ratio (quarterly & annually)

How has BCAX PE Ratio performed in the past?

The mean historical PE Ratio of Bicara Therapeutics Inc. Common Stock over the last ten years is -23.09. The current 3.49 PE Ratio has changed -1611.47% with respect to the historical average. Over the past ten years (40 quarters), BCAX's PE Ratio was at its highest in in the June 2025 quarter at -4.62. The PE Ratio was at its lowest in in the March 2023 quarter at -38.27.

Bicara Therapeutics Inc. Common Stock (BCAX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bicara Therapeutics Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bicara Therapeutics Inc. Common Stock (BCAX) Average PE Ratio

How has BCAX PE Ratio performed in the past?

The current PE Ratio of Bicara Therapeutics Inc. Common Stock (BCAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bicara Therapeutics Inc. Common Stock (BCAX) PE Ratio vs. Peers

How is BCAX’s PE Ratio compared to its peers?

Bicara Therapeutics Inc. Common Stock’s PE Ratio is greater than Kura Oncology, Inc. (-4.84), greater than Septerna, Inc. (-19.73), greater than EyePoint Pharmaceuticals, Inc. (-5.70), greater than ProKidney Corp. (-4.64), greater than Prime Medicine, Inc. (-3.13), greater than Tango Therapeutics, Inc. (-7.52), greater than Phathom Pharmaceuticals, Inc. (-3.93), greater than Maravai LifeSciences Holdings, Inc. (-4.42), greater than Savara Inc. (-12.50), greater than Fortrea Holdings Inc. (-1.30),

Build a custom stock screener for Bicara Therapeutics Inc. Common Stock (BCAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bicara Therapeutics Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bicara Therapeutics Inc. Common Stock (BCAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bicara Therapeutics Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.